SlideShare a Scribd company logo
CAPTURE Instrument: COPD Assessment in Primary Care To Identify
Undiagnosed Respiratory Disease and Exacerbation Risk1
Full abbreviations, accreditation, and disclosure information available at PeerView.com/NBT40
1. Martinez FJ et al. Am J Respir Crit Care Med. 2017;195:748-756.
Please answer each question No Yes
1. Have you ever lived or worked in a place with dirty or polluted air, smoke, second-hand smoke, or dust?  
2. Does your breathing change with seasons, weather, or air quality?  
3. 
Does your breathing make it difficult to do things such as carry heavy loads, shovel dirt or snow, jog,
play tennis, or swim?
 
4. Compared with others your age, do you tire easily?  
5. 
In the past 12 months, how many times did you miss work, school, or other activities because of a cold,
bronchitis, or pneumonia?
  
For Clinical Use No Yes
PEF, L/min (Recommended for scores ≥2; best of three tests)
Men: 350 L/min  
Women: 250 L/min  
0 1 ≥2
American Lung Association:
My COPD Action Plan1
Full abbreviations, accreditation, and disclosure information available at
PeerView.com/NBT40
It is recommended that patients and physicians/healthcare providers
complete this action plan together.
This plan should be discussed at each physician visit and updated as needed.
The green, yellow, and red zones show symptoms of COPD. The list of symptoms is not comprehensive,
and you may experience other symptoms. In the “Actions” column, your healthcare provider will recommend
actions for you to take based on your symptoms by checking the appropriate boxes. Your healthcare provider
may write down other actions in addition to those listed here.
a
The American Lung Association recommends that providers select this action for all patients.
1. https://www.lung.org/getmedia/c7657648-a30f-4465-af92-fc762411922e/fy20-ala-copd-action-plan.pdf.
Yellow Zone: I am having a bad day or a COPD flare Actions
• More breathless than usual
• I have less energy for my daily activities
• Increased or thicker phlegm/mucus
• Using quick-relief inhaler/nebulizer more often
• Swelling of ankles more than usual
• More coughing than usual
• I feel like I have a “chest cold”
• Poor sleep and my symptoms woke me up
• My appetite is not good
• My medicine is not helping
 Continue daily medication
 Use quick-relief inhaler every hours
 Start an oral corticosteroid(specifyname,dose,andduration)
 Start an antibiotic (specifyname,dose,andduration)
 Use oxygen as prescribed
 Get plenty of rest
 Use pursed-lip breathing
 Avoid cigarette smoke and inhaled irritants at all timesa
 Call provider immediately if symptoms don’t improvea

Red Zone: I need urgent medical care Actions
• Severe shortness of breath even at rest
• Not able to do any activity because of breathing
• Not able to sleep because of breathing
• Fever or shaking chills
• Feeling confused or very drowsy
• Chest pains
• Coughing up blood
 Call 911 or seek medical care immediatelya
 While getting help, immediately do the following:
Green Zone: I am doing well today Actions
• Usual activity and exercise level
• Usual amounts of cough and phlegm/mucus
• Sleep well at night
• Appetite is good
 Take daily medicines
 Use oxygen as prescribed
 Continue regular exercise/diet plan
 Avoid cigarette smoke and inhaled irritants at all timesa

American Lung Association:
My COPD Management Plan1
Full abbreviations, accreditation, and disclosure information available at
PeerView.com/NBT40
It is recommended that patients and physicians/healthcare providers complete this management plan
together. This plan should be discussed at each physician visit and updated as needed.
Name:
Emergency contact:
Physician/healthcare provider name:
Type or Description of Medicines Name of Medicine How Much to Take When to Take
Date:
Phone number:
Phone number:
Flu vaccine:
Pneumococcal conjugate vaccine (PCV13)
 Yes  No
Pneumococcal polysaccharide vaccine (PPSV23)
 Yes  No
 Advise: Firmly recommend quitting smoking
 Assess readiness to quit
 Encourage to pick a quit date
 Assist with a specific cessation plan that can include materials, resources, referrals, and aids
 Anemia
 Diabetes
 Osteoporosis
 Anxiety/panic  Arthritis Blood clots Cancer Depression
 GERD/acid reflux  Heart disease High blood pressure Insomnia Kidney/prostate
 Other:
 Discuss use of medications, if appropriate:
 Freedom From Smokinga
Lung.org/ffs
 Lung HelpLine 1-800-LUNG USA
Smoking status:  Never  Past  Current
Exercise plan:  Yes  No
Diet plan:  Yes  No
 Walking  Other
min/day days/week
Quit smoking plan:  Yes  No
Date received:
Date received:
Date received:
Pulmonary rehabilitation:
 Yes  No
Goal Weight
Next flu vaccine due:
Next PCV13 vaccine due:
Next PPSV23 vaccine due:
Lung Function Measurements
Medications for COPD
My Quit Smoking Plan
General Information
Resting: Increased activity: Sleeping:
Oxygen
Advanced directives (including healthcare power of attorney):
Advanced Care and Planning Options
Other Health Conditions
a
The American Lung Association recommends that providers select this action for all patients.
1. https://www.lung.org/getmedia/c7657648-a30f-4465-af92-fc762411922e/fy20-ala-copd-action-plan.pdf.

More Related Content

Similar to Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care

Caring for COPD
Caring for COPDCaring for COPD
Caring for COPD
ConsidraCare
 
copdscreenfinalrsfact.pdf
copdscreenfinalrsfact.pdfcopdscreenfinalrsfact.pdf
copdscreenfinalrsfact.pdf
Moses671164
 
Wk 6 simple:good asthma presentation 2
Wk 6 simple:good asthma presentation 2Wk 6 simple:good asthma presentation 2
Wk 6 simple:good asthma presentation 2
Beth Swanson
 
Emphysema
EmphysemaEmphysema
Emphysema
fitango
 
Asthma and COPD Care Pathways.ppt
Asthma and COPD Care Pathways.pptAsthma and COPD Care Pathways.ppt
Asthma and COPD Care Pathways.ppt
RagiaOmar
 
Gina - global initiative against asthma
Gina - global initiative against asthmaGina - global initiative against asthma
Gina - global initiative against asthma
adithya2115
 
Living-Well-With-COPD.pdf
Living-Well-With-COPD.pdfLiving-Well-With-COPD.pdf
Living-Well-With-COPD.pdf
MadalinaCiochina
 
Living-Well-With-COPD.pdf
Living-Well-With-COPD.pdfLiving-Well-With-COPD.pdf
Living-Well-With-COPD.pdf
MadalinaCiochina
 
Copd
Copd Copd
Medication safety - Second Lecture
Medication safety - Second LectureMedication safety - Second Lecture
Medication safety - Second Lecture
Kurt Wilson
 
Lecture 2 2011 1 pharm (student)-1
Lecture 2 2011 1 pharm (student)-1Lecture 2 2011 1 pharm (student)-1
Lecture 2 2011 1 pharm (student)-1
University of Miami
 
Q1 W1 D2.pdf
Q1 W1 D2.pdfQ1 W1 D2.pdf
Q1 W1 D2.pdf
MARJRegalado
 
Module c week 4 copy
Module c week 4   copyModule c week 4   copy
Module c week 4 copy
ClaudiaKim7
 
OTC Medication.pdf
OTC Medication.pdfOTC Medication.pdf
OTC Medication.pdf
Dr Ravikiran S
 
SCIENCE 9 Q1 W1 D2.pptx
SCIENCE 9 Q1 W1 D2.pptxSCIENCE 9 Q1 W1 D2.pptx
SCIENCE 9 Q1 W1 D2.pptx
MARJRegalado
 
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptxPATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
Lipanjali Badhei
 
Approach to internship (mbbs in bangladesh perspective)
Approach to internship (mbbs in bangladesh perspective)Approach to internship (mbbs in bangladesh perspective)
Approach to internship (mbbs in bangladesh perspective)
Pritom Das
 
bronchial asthma.ppt
bronchial asthma.pptbronchial asthma.ppt
bronchial asthma.ppt
PreetiSharma428161
 
Improving lung function after smoking cessation
Improving lung function after smoking cessationImproving lung function after smoking cessation
Improving lung function after smoking cessation
Jane Allen
 
Fighting COPD
Fighting COPDFighting COPD
Fighting COPD
BrightStar Care
 

Similar to Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care (20)

Caring for COPD
Caring for COPDCaring for COPD
Caring for COPD
 
copdscreenfinalrsfact.pdf
copdscreenfinalrsfact.pdfcopdscreenfinalrsfact.pdf
copdscreenfinalrsfact.pdf
 
Wk 6 simple:good asthma presentation 2
Wk 6 simple:good asthma presentation 2Wk 6 simple:good asthma presentation 2
Wk 6 simple:good asthma presentation 2
 
Emphysema
EmphysemaEmphysema
Emphysema
 
Asthma and COPD Care Pathways.ppt
Asthma and COPD Care Pathways.pptAsthma and COPD Care Pathways.ppt
Asthma and COPD Care Pathways.ppt
 
Gina - global initiative against asthma
Gina - global initiative against asthmaGina - global initiative against asthma
Gina - global initiative against asthma
 
Living-Well-With-COPD.pdf
Living-Well-With-COPD.pdfLiving-Well-With-COPD.pdf
Living-Well-With-COPD.pdf
 
Living-Well-With-COPD.pdf
Living-Well-With-COPD.pdfLiving-Well-With-COPD.pdf
Living-Well-With-COPD.pdf
 
Copd
Copd Copd
Copd
 
Medication safety - Second Lecture
Medication safety - Second LectureMedication safety - Second Lecture
Medication safety - Second Lecture
 
Lecture 2 2011 1 pharm (student)-1
Lecture 2 2011 1 pharm (student)-1Lecture 2 2011 1 pharm (student)-1
Lecture 2 2011 1 pharm (student)-1
 
Q1 W1 D2.pdf
Q1 W1 D2.pdfQ1 W1 D2.pdf
Q1 W1 D2.pdf
 
Module c week 4 copy
Module c week 4   copyModule c week 4   copy
Module c week 4 copy
 
OTC Medication.pdf
OTC Medication.pdfOTC Medication.pdf
OTC Medication.pdf
 
SCIENCE 9 Q1 W1 D2.pptx
SCIENCE 9 Q1 W1 D2.pptxSCIENCE 9 Q1 W1 D2.pptx
SCIENCE 9 Q1 W1 D2.pptx
 
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptxPATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
PATIENT COUNSELLING POINTS FOR CHRONIC DISEASES.pptx
 
Approach to internship (mbbs in bangladesh perspective)
Approach to internship (mbbs in bangladesh perspective)Approach to internship (mbbs in bangladesh perspective)
Approach to internship (mbbs in bangladesh perspective)
 
bronchial asthma.ppt
bronchial asthma.pptbronchial asthma.ppt
bronchial asthma.ppt
 
Improving lung function after smoking cessation
Improving lung function after smoking cessationImproving lung function after smoking cessation
Improving lung function after smoking cessation
 
Fighting COPD
Fighting COPDFighting COPD
Fighting COPD
 

More from PVI, PeerView Institute for Medical Education

Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
PVI, PeerView Institute for Medical Education
 
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
PVI, PeerView Institute for Medical Education
 
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
PVI, PeerView Institute for Medical Education
 
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
PVI, PeerView Institute for Medical Education
 
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
PVI, PeerView Institute for Medical Education
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
Adapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use DisorderAdapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use Disorder
PVI, PeerView Institute for Medical Education
 
Adapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use DisorderAdapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use Disorder
PVI, PeerView Institute for Medical Education
 
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
PVI, PeerView Institute for Medical Education
 
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
PVI, PeerView Institute for Medical Education
 
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
PVI, PeerView Institute for Medical Education
 
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
PVI, PeerView Institute for Medical Education
 
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
PVI, PeerView Institute for Medical Education
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
PVI, PeerView Institute for Medical Education
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
PVI, PeerView Institute for Medical Education
 
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
PVI, PeerView Institute for Medical Education
 
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
PVI, PeerView Institute for Medical Education
 
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
PVI, PeerView Institute for Medical Education
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
PVI, PeerView Institute for Medical Education
 

More from PVI, PeerView Institute for Medical Education (20)

Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
Improving Outcomes for Pediatric Patients With Uncontrolled Moderate-to-Sever...
 
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
 
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
Safeguarding Patients With HR+, HER2-, High-Risk, Early Breast Cancer: A Prac...
 
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
 
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standard...
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
Adapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use DisorderAdapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use Disorder
 
Adapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use DisorderAdapting HIV Treatment for People With Substance Use Disorder
Adapting HIV Treatment for People With Substance Use Disorder
 
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
Aligning Clinical Practice With Emerging Evidence: Navigating the Rapidly Evo...
 
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
Experts vs AI: Who Is Better at Monitoring and Treating MASLD and MASH?
 
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
Five Steps for Integrating BCMA Bispecific Innovations: From Clinical Data to...
 
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understandi...
 
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
Establishing the Collaborative Benchmark for HCC Care: Critical Discussions B...
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
 
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
Bridging the Gap to Improved Outcomes in Non-Cystic Fibrosis Bronchiectasis: ...
 
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
Applying Advances in PET Imaging to Facilitate the Early Diagnosis of Alzheim...
 
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
A Pharmacist’s Take on Navigating the Expanding Therapeutic Landscape for End...
 
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
“Four-Ward” Progress in NDMM: New Developments With CD38 Antibody Quadruplets
 
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable N...
 

Recently uploaded

Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 

Recently uploaded (20)

Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 

Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care

  • 1. CAPTURE Instrument: COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk1 Full abbreviations, accreditation, and disclosure information available at PeerView.com/NBT40 1. Martinez FJ et al. Am J Respir Crit Care Med. 2017;195:748-756. Please answer each question No Yes 1. Have you ever lived or worked in a place with dirty or polluted air, smoke, second-hand smoke, or dust?   2. Does your breathing change with seasons, weather, or air quality?   3. Does your breathing make it difficult to do things such as carry heavy loads, shovel dirt or snow, jog, play tennis, or swim?   4. Compared with others your age, do you tire easily?   5. In the past 12 months, how many times did you miss work, school, or other activities because of a cold, bronchitis, or pneumonia?    For Clinical Use No Yes PEF, L/min (Recommended for scores ≥2; best of three tests) Men: 350 L/min   Women: 250 L/min   0 1 ≥2
  • 2. American Lung Association: My COPD Action Plan1 Full abbreviations, accreditation, and disclosure information available at PeerView.com/NBT40 It is recommended that patients and physicians/healthcare providers complete this action plan together. This plan should be discussed at each physician visit and updated as needed. The green, yellow, and red zones show symptoms of COPD. The list of symptoms is not comprehensive, and you may experience other symptoms. In the “Actions” column, your healthcare provider will recommend actions for you to take based on your symptoms by checking the appropriate boxes. Your healthcare provider may write down other actions in addition to those listed here. a The American Lung Association recommends that providers select this action for all patients. 1. https://www.lung.org/getmedia/c7657648-a30f-4465-af92-fc762411922e/fy20-ala-copd-action-plan.pdf. Yellow Zone: I am having a bad day or a COPD flare Actions • More breathless than usual • I have less energy for my daily activities • Increased or thicker phlegm/mucus • Using quick-relief inhaler/nebulizer more often • Swelling of ankles more than usual • More coughing than usual • I feel like I have a “chest cold” • Poor sleep and my symptoms woke me up • My appetite is not good • My medicine is not helping  Continue daily medication  Use quick-relief inhaler every hours  Start an oral corticosteroid(specifyname,dose,andduration)  Start an antibiotic (specifyname,dose,andduration)  Use oxygen as prescribed  Get plenty of rest  Use pursed-lip breathing  Avoid cigarette smoke and inhaled irritants at all timesa  Call provider immediately if symptoms don’t improvea  Red Zone: I need urgent medical care Actions • Severe shortness of breath even at rest • Not able to do any activity because of breathing • Not able to sleep because of breathing • Fever or shaking chills • Feeling confused or very drowsy • Chest pains • Coughing up blood  Call 911 or seek medical care immediatelya  While getting help, immediately do the following: Green Zone: I am doing well today Actions • Usual activity and exercise level • Usual amounts of cough and phlegm/mucus • Sleep well at night • Appetite is good  Take daily medicines  Use oxygen as prescribed  Continue regular exercise/diet plan  Avoid cigarette smoke and inhaled irritants at all timesa 
  • 3. American Lung Association: My COPD Management Plan1 Full abbreviations, accreditation, and disclosure information available at PeerView.com/NBT40 It is recommended that patients and physicians/healthcare providers complete this management plan together. This plan should be discussed at each physician visit and updated as needed. Name: Emergency contact: Physician/healthcare provider name: Type or Description of Medicines Name of Medicine How Much to Take When to Take Date: Phone number: Phone number: Flu vaccine: Pneumococcal conjugate vaccine (PCV13)  Yes  No Pneumococcal polysaccharide vaccine (PPSV23)  Yes  No  Advise: Firmly recommend quitting smoking  Assess readiness to quit  Encourage to pick a quit date  Assist with a specific cessation plan that can include materials, resources, referrals, and aids  Anemia  Diabetes  Osteoporosis  Anxiety/panic  Arthritis Blood clots Cancer Depression  GERD/acid reflux  Heart disease High blood pressure Insomnia Kidney/prostate  Other:  Discuss use of medications, if appropriate:  Freedom From Smokinga Lung.org/ffs  Lung HelpLine 1-800-LUNG USA Smoking status:  Never  Past  Current Exercise plan:  Yes  No Diet plan:  Yes  No  Walking  Other min/day days/week Quit smoking plan:  Yes  No Date received: Date received: Date received: Pulmonary rehabilitation:  Yes  No Goal Weight Next flu vaccine due: Next PCV13 vaccine due: Next PPSV23 vaccine due: Lung Function Measurements Medications for COPD My Quit Smoking Plan General Information Resting: Increased activity: Sleeping: Oxygen Advanced directives (including healthcare power of attorney): Advanced Care and Planning Options Other Health Conditions a The American Lung Association recommends that providers select this action for all patients. 1. https://www.lung.org/getmedia/c7657648-a30f-4465-af92-fc762411922e/fy20-ala-copd-action-plan.pdf.